Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic Cancer
Wungki Park, Akhil Chawla, Eileen M. O’Reilly
JAMA (2021) Vol. 326, Iss. 9, pp. 851-851
Open Access | Times Cited: 1126

Showing 51-75 of 1126 citing articles:

Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer
Stefano Crippa, Giuseppe Malleo, Vincenzo Mazzaferro, et al.
JAMA Surgery (2024) Vol. 159, Iss. 10, pp. 1139-1139
Open Access | Times Cited: 14
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1614-1629.e5
Closed Access | Times Cited: 14
Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030
Ru He, Wenkai Jiang, Chenyu Wang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma
Ben George, Olga Kudryashova, Andrey Kravets, et al.
Gastroenterology (2024) Vol. 166, Iss. 5, pp. 859-871.e3
Closed Access | Times Cited: 12
Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study
Hajime Yamazaki, Samantha A. Streicher, Lang Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101391-101391
Open Access | Times Cited: 12
Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer
Yuchao Zhu, Shuai Fang, Bolin Fan, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1683-1700
Open Access | Times Cited: 12
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study
Mark Ayoub, Carol Faris, Tajana Juranovic, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1625-1625
Open Access | Times Cited: 12
Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3.
Oscar Fraile‐Martínez, Cielo García‐Montero, Leonel Pekarek, et al.
PubMed (2024) Vol. 39, Iss. 1, pp. 35-40
Closed Access | Times Cited: 11
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study
Christelle de la Fouchardière, David Malka, Claire Cropet, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 9, pp. 1055-1066
Closed Access | Times Cited: 11
Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer
Yohei Ando, Mohamad Dbouk, Takeichi Yoshida, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 18, pp. 2196-2206
Open Access | Times Cited: 11
The Role of Transglutaminase 2 in Cancer: An Update
Elisabetta Zaltron, Federica Vianello, Alessia Ruzza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2797-2797
Open Access | Times Cited: 10
A Phenotypic Approach to the Discovery of Potent G-Quadruplex Targeted Drugs
Stephen Neidle
Molecules (2024) Vol. 29, Iss. 15, pp. 3653-3653
Open Access | Times Cited: 10
Pancreatic Cancer Cell-derived Migrasomes Promote Cancer Progression by Fostering an Immunosuppressive Tumor Microenvironment
Ronghua Zhang, Junya Peng, Yalu Zhang, et al.
Cancer Letters (2024) Vol. 605, pp. 217289-217289
Closed Access | Times Cited: 10
KPC-luciferase-expressing cells elicit an anti-tumor immune response in a mouse model of pancreatic cancer
Daniele Ferrari, Fernanda Ramos-Gomes, Frauke Alves, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence
Ashwin Mukund, Muhammad Ali Afridi, Aleksandra Karolak, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2240-2240
Open Access | Times Cited: 9
Microbiome and pancreatic cancer: time to think about chemotherapy
Juliana de Castilhos, Katharina Tillmanns, J. A. BLESSING, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P. Botta, Maen Abdelrahim, Ronald Drengler, et al.
The Oncologist (2024) Vol. 29, Iss. 10, pp. 859-869
Open Access | Times Cited: 9
Current understanding of functional peptides encoded by lncRNA in cancer
Hua Tian, Lu Tang, Zihan Yang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Barriers and opportunities in pancreatic cancer immunotherapy
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
Yuexiang Liang, Guannan Sheng, Yu Guo, et al.
Cancer Biology and Medicine (2024), pp. 1-17
Open Access | Times Cited: 8
Role of STAT3 in pancreatic cancer
Zachary Hamel, S. Calabrese Sánchez, David Standing, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 20-33
Open Access | Times Cited: 8
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
Taha Koray Şahin, Yakup Özbay, Ahmet Yasir Altunbulak, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 6, pp. 822-831
Closed Access | Times Cited: 8
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer
Michael Cecchini, Ronald R. Salem, Marie E. Robert, et al.
JAMA Oncology (2024) Vol. 10, Iss. 8, pp. 1027-1027
Open Access | Times Cited: 8
Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer
Hanming Yao, Chengzhi Huang, Jinmao Zou, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 8
Multiparametric MRI for Assessment of the Biological Invasiveness and Prognosis of Pancreatic Ductal Adenocarcinoma in the Era of Artificial Intelligence
Ben Y. Zhao, Buyue Cao, Tianyi Xia, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access | Times Cited: 1

Scroll to top